Cancer patients who exercise have less heart damage from chemotherapy
A paper published by the European Journal of Preventative Cardiology reports that cancer patients who exercise have less heart damage from chemotherapy... Read More
Survival Outcomes of Gastric and Gastroesophageal Junction Adenocarcinomas Treated With Perioperative Chemotherapy ± Preoperative Radiotherapy
A new study of patients with early- and mid-stage gastric cancer found that those treated with chemo and radiation before surgery were... Read More
A possible gut-brain connection to ‘chemo brain’
Got chemo brain? Your digestive system may be to blame, according to research from Ohio State University.
Better Short-Term Results With LADG in Stomach Cancer
A study found that patients who undergo minimally invasive laparoscopic gastrectomy are better able to tolerate chemotherapy for gastric cancer than are... Read More
Survival Benefit of Palliative Gastrectomy Followed by Chemotherapy for Stage IV Gastric Signet Ring Cell Carcinoma
Gastrectomy followed by chemotherapy can be more effective than chemo alone in gastric cancer patients with signet ring cell carcinoma, according to... Read More
Optimal Duration of First-Line Chemotherapy for Advanced Gastric Cancer: Data from the AGAMENON Registry
A study concludes that longer first-line chemotherapy regimens for patients with gastric cancer has a protective effect, and that discontinuing platinum chemo... Read More
New Combination Shows Early Promise in Gastric Cancer
A combo of the immuno-oncology drug Keytruda with the VEGFR-2 inhibitor Cyramza was well tolerated by gastric cancer patients in a phase... Read More
Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination With D2 Gastrectomy
A recent study found that the XELOX chemo regimen given before and after surgery in patients with locally advanced gastric cancer was... Read More
Perioperative FOLFIRINOX for Gastroesophageal Adenocarcinoma
In a trial, the chemotherapy regimen FOLFIRINOX produced response rates on par with FLOT and may be easier to tolerate, says Dan... Read More
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
Adding Tykerb to chemotherapy in HER-2 positive gastric cancer patients was proven safe in a phase 2 trial